{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:50:13Z","timestamp":1761763813644},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/bcr445","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A49T, V89L and TA repeat polymorphisms of steroid 5\u03b1-reductase type II and breast cancer risk in Japanese women"],"prefix":"10.1186","volume":"4","author":[{"given":"Chunxia","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hamajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroji","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Takezaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,8,1]]},"reference":[{"key":"449_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/carcin\/21.3.427","volume":"21","author":"BE Henderson","year":"2000","unstructured":"Henderson BE, Feigelson HS: Hormonal carcinogenesis. Carcinogenesis. 2000, 21: 427-433. 10.1093\/carcin\/21.3.427.","journal-title":"Carcinogenesis"},{"key":"449_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.annonc.a058230","volume":"3","author":"BA Stoll","year":"1992","unstructured":"Stoll BA, Secreto G: New hormone-related markers of high risk to breast cancer. Ann Oncol. 1992, 3: 435-438.","journal-title":"Ann Oncol"},{"key":"449_CR3","first-page":"749","volume":"21","author":"B Budai","year":"2001","unstructured":"Budai B, Szamel I, Sulyok Z, Nemet M, Bak M, Otto S, Reed MJ, Purohit A, Parish DC, Kralovanszky J: Characteristics of cystic breast disease with special regard to breast cancer development. Anticancer Res. 2001, 21: 749-752.","journal-title":"Anticancer Res"},{"key":"449_CR4","first-page":"533","volume":"5","author":"JF Dorgan","year":"1996","unstructured":"Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A: Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996, 5: 533-539.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"449_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jnci\/88.5.291","volume":"88","author":"F Berrino","year":"1996","unstructured":"Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G: Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 1996, 88: 291-296.","journal-title":"J Natl Cancer Inst"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00004","volume":"130","author":"JA Cauley","year":"1999","unstructured":"Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR: Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med. 1999, 130: 270-277.","journal-title":"Ann Intern Med"},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1210\/endo.142.10.8417","volume":"142","author":"J Lapointe","year":"2001","unstructured":"Lapointe J, Labrie C: Role of the cyclin-dependent kinase inhibitor p27(Kip1) in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation. Endocrinology. 2001, 142: 4331-4338.","journal-title":"Endocrinology"},{"key":"449_CR8","first-page":"3131","volume":"51","author":"S Dauvois","year":"1991","unstructured":"Dauvois S, Geng CS, Levesque C, Merand Y, Labrie F: Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. Cancer Res. 1991, 51: 3131-3135.","journal-title":"Cancer Res"},{"key":"449_CR9","first-page":"31","volume":"16","author":"F Labrie","year":"1992","unstructured":"Labrie F, Simard J, de Launoit Y, Poulin R, Theriault C, Dumont M, Dauvois S, Martel C, Li SM: Androgens and breast cancer. Cancer Detect Prev. 1992, 16: 31-38.","journal-title":"Cancer Detect Prev"},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/1097-0142(19910215)67:4<886::AID-CNCR2820670405>3.0.CO;2-O","volume":"67","author":"JN Ingle","year":"1991","unstructured":"Ingle JN, Twito DI, Schaid DJ, Cullinan SA, Krook JE, Mailliard JA, Tschetter LK, Long HJ, Gerstner JG, Windschitl HE: Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis. Cancer. 1991, 67: 886-891.","journal-title":"Cancer"},{"key":"449_CR11","first-page":"2250","volume":"86","author":"T Suzuki","year":"2001","unstructured":"Suzuki T, Darnel AD, Akahira JI, Ariga N, Ogawa S, Kaneko C, Takeyama J, Moriya T, Sasano H: 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions. J Clin Endocrinol Metab. 2001, 86: 2250-2257.","journal-title":"J Clin Endocrinol Metab"},{"key":"449_CR12","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1210\/endo.131.3.1505484","volume":"131","author":"F Labrie","year":"1992","unstructured":"Labrie F, Sugimoto Y, Luu-The V, Simard J, Lachance Y, Bach-varov D, Leblanc G, Durocher F, Paquet N: Structure of human type II 5 alpha-reductase gene. Endocrinology. 1992, 131: 1571-1573.","journal-title":"Endocrinology"},{"key":"449_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-2265.2000.00941.x","volume":"52","author":"F Vichis","year":"2000","unstructured":"Vichis F, Mendez JP, Canto P, Lieberman E, Chavez B: Identification of missense mutations in the SRD5A2 gene from patients with steroid 5\u03b1-reductase 2 deficiency. Clin Endocrinol. 2000, 52: 383-387. 10.1046\/j.1365-2265.2000.00941.x.","journal-title":"Clin Endocrinol"},{"key":"449_CR14","first-page":"1020","volume":"57","author":"N Makridakis","year":"1997","unstructured":"Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN: A prevalent missense substitution that modulates activity of prostatic steroid 5\u03b1-reductase. Cancer Res. 1997, 57: 1020-1022.","journal-title":"Cancer Res"},{"key":"449_CR15","first-page":"185","volume":"10","author":"NE Allen","year":"2001","unstructured":"Allen NE, Forrest MS, Key TJ: The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev. 2001, 10: 185-189.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"449_CR16","first-page":"3973","volume":"55","author":"JK Reichardt","year":"1995","unstructured":"Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK: Genetic variability of the human SRD5A2 gene: implication for prostate cancer risk. Cancer Res. 1995, 55: 3973-3975.","journal-title":"Cancer Res"},{"key":"449_CR17","first-page":"1077","volume":"10","author":"AW Hsing","year":"2001","unstructured":"Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK: Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case\u2013control study. Cancer Epidemiol Biomarkers Prev. 2001, 10: 1077-1082.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"449_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0140-6736(98)11282-5","volume":"354","author":"NM Makridakis","year":"1999","unstructured":"Makridakis NM, Ross RK, Pike MC, Crocitto LE, Kolone LN, Pearce CL, Henderson BE, Reichardt JK: Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet. 1999, 354: 975-978. 10.1016\/S0140-6736(98)11282-5.","journal-title":"Lancet"},{"key":"449_CR19","first-page":"387","volume":"9","author":"B Bharaj","year":"2000","unstructured":"Bharaj B, Scorilas A, Giai M, Diamandis EP: TA repeat polymorphism of the 5\u03b1-reductase gene and breast cancer. Cancer Epidemiol Biomarkers Prev. 2000, 9: 387-393.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"449_CR20","first-page":"189","volume":"6","author":"PW Kantoff","year":"1997","unstructured":"Kantoff PW, Febbo PG, Giovannucci E, Krithivas K, Dahl DM, Chang G, Hennekens CH, Brown M, Stamper MJ: A polymorphism of the 5 alpha reductase gene and its association with prostate cancer: a case\u2013control analysis. Cancer Epidemiol Biomarkers Prev. 1997, 6: 189-192.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"449_CR21","first-page":"5878","volume":"59","author":"PG Febbo","year":"1999","unstructured":"Febbo PG, Kantoff PW, Platz EA, Casey D, Batter S, Giovannucci E, Hennekens CH, Stampfer MJ: The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer. Cancer Res. 1999, 59: 5878-5881.","journal-title":"Cancer Res"},{"key":"449_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1155\/2000\/683607","volume":"16","author":"K Margiotti","year":"2000","unstructured":"Margiotti K, Sangiuolo F, De Luca A, Froio F, Pearce CL, Ricci-Barbini V, Micali F, Bonafe M, Franceschi C, Dallapiccola B, Novelli G, Reichardt JK: Evidence for an association between the SRD5A2 (type II steroid 5 alpha-reductase) locus and prostate cancer in Italian patients. Dis Markers. 2000, 16: 147-150.","journal-title":"Dis Markers"},{"key":"449_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B","volume":"92","author":"AG Latil","year":"2001","unstructured":"Latil AG, Azzouzi R, Cancel GS, Guillaume EC, Cochan-Priollet B, Berthon PL, Cussenot O: Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer. 2001, 92: 1130-1137. 10.1002\/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B.","journal-title":"Cancer"},{"key":"449_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/1097-0215(20010601)92:5<683::AID-IJC1255>3.0.CO;2-4","volume":"92","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Watanabe M, Murata M, Yamanaka M, Kubota Y, Ito H, Katoh T, Kawamura J, Yatani R, Shiraishi T: Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5\u03b1-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population. Int J Cancer. 2001, 92: 683-686. 10.1002\/1097-0215(20010601)92:5<683::AID-IJC1255>3.0.CO;2-4.","journal-title":"Int J Cancer"},{"key":"449_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0090-4295(00)00928-6","volume":"57","author":"RK Nam","year":"2001","unstructured":"Nam RK, Toi A, Vesprini D, Ho M, Chu W, Harvie S, Sweet J, Trachtenberg J, Jewett MA, Narod SA: V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology. 2001, 57: 199-204. 10.1016\/S0090-4295(00)00928-6.","journal-title":"Urology"},{"key":"449_CR26","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1054\/bjoc.2001.1789","volume":"84","author":"N Mononen","year":"2001","unstructured":"Mononen N, Ikonen T, Syrjakoski K, Matikainen M, Schleutker J, Tammela TLJ, Koivisto PA, Kallioniemi OP: A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A21) is not associated with prostate cancer in Finland. Br J Cancer. 2001, 84: 1344-1347. 10.1054\/bjoc.2001.1789.","journal-title":"Br J Cancer"},{"key":"449_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1054\/bjoc.2000.1681","volume":"84","author":"A Scorilas","year":"2001","unstructured":"Scorilas A, Bharaj B, Gial M, Diamandis EP: Codon 89 polymorphisms in the human 5\u03b1-reductase gene in primary breast cancer. Br J Cancer. 2001, 84: 760-767. 10.1054\/bjoc.2000.1681.","journal-title":"Br J Cancer"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/bcr304","volume":"3","author":"XE Huang","year":"2001","unstructured":"Huang XE, Hamajima N, Saito T, Matsuo K, Mizutani M, Iwata H, Iwase T, Miura S, Mizuno T, Tokudome S, Tajima K: Possible association of \u03b22- and \u03b23-adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Res. 2001, 3: 264-269. 10.1186\/bcr304.","journal-title":"Breast Cancer Res"},{"key":"449_CR29","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1349-7006.2000.tb01026.x","volume":"91","author":"N Hamajima","year":"2000","unstructured":"Hamajima N, Saito T, Matsuo K, Kozaki KI, Takahashi T, Tajima K: Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res. 2000, 91: 865-868.","journal-title":"Jpn J Cancer Res"},{"key":"449_CR30","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/oxfordjournals.aje.a009059","volume":"145","author":"A Zeleniuch-Jacquotte","year":"1997","unstructured":"Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, Koenig KL, Shore RE, Kim MY, Pasternack BS, Toniolo P: Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol. 1997, 145: 1030-1038.","journal-title":"Am J Epidemiol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr445\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:22:11Z","timestamp":1714062131000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,1]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2002,8]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1186\/bcr445","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,1]]},"assertion":[{"value":"15 December 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2002","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2002","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2002","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"R8"}}